Bone disease is an important metabolic complication of HIV infection. Studies have demonstrated that osteopenia and osteoporosis occur earlier and more frequently in those infected with HIV than in the uninfected. However, bone health remains a relatively neglected area of preventive care in this population due to limited evidence for recommended screening and treatment practices in this group and concerns about drug toxicity. A didactic presentation and handouts will provide available evidence based background information on current issues and newer recommendation and algorithms. Small “break out” groups will evaluate clinical cases relating to specific topics in bone health and devise a screening and intervention plan for each case. Discussion from these groups will be presented to the large group at the conclusion of the workshop with the goal of consensus building for this very important issue in primary care for the HIV infected.
Learning Objectives: